Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · CIK 1420800 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $29.30Day −3.17%Mkt cap $1.7B1Y +8.4%Off 52W high −14.5%Vol (1Y) 59.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,078 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest14.5% of sh out |
| Days to cover6.6d |
| 13F net flow (QoQ)+5.99% |
| Top-10 13F concentration51.3% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$2.28B |
| Earnings (TTM)-$1.14B |
| ROE−58.5% |
| Net margin−52.7% |
| ROIC−26.9% |
| Debt / equity0.87× |
| Total debt / EBITDA5.90× |
| Sales growth 3Y12.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+10.0% |
| 1Y+8.4% |
| 3Y−54.1% |
| Since incept. (ann.)−18.0% |
Total return through 2026-07-30 · series begins 2022-04-06. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)59.6% |
| Ann. volatility (3Y)46.1% |
| Sharpe (1Y)0.41 |
| Sharpe (3Y)−0.34 |
| Max drawdown (1Y)−39.9% |
| Max drawdown (3Y)−68.6% |
| Beta (3Y vs SPY)0.82 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 9.9M | $226M | 17.36% | +11.6% |
| AMERICAN CENTURY COMPANIES INC | 4.8M | $108M | 8.33% | −9.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.8M | $87M | 6.65% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $58M | 4.46% | new |
| DIMENSIONAL FUND ADVISORS LP | 2.5M | $58M | 4.45% | −8.5% |
| Rubric Capital Management LP | 2.5M | $56M | 4.29% | +0.0% |
| DAVENPORT & Co LLC | 2.4M | $55M | 4.26% | −0.0% |
| STATE STREET CORP | 2.4M | $55M | 4.20% | +1.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 117.2% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 9,230,699 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-04-03 | 2026-05-07 | −$0.15 | — | $589.2M | +5.4% |
| 2025-12-31 | 2026-02-26 | — | — | $575.8M | +2.6% |
| 2025-10-03 | 2025-11-06 | −$9.99 | — | $548.9M | +8.6% |
| 2025-07-04 | 2025-08-07 | −$0.64 | — | $564.5M | +7.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Prevention And Recovery 51% · Reconstructive 49%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
